# Extending the Time Window for Tenecteplase by Effective Reperfusion in Patients with Large Vessel Occlusion

Study · id `cardio:ct-nct04454788` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04454788](<https://clinicaltrials.gov/study/NCT04454788>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04454788

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 242 participants.

## Technical summary

Registry record NCT04454788. Randomized; no masking; primary purpose treatment. Start 2020-08-01 (actual); primary completion 2024-07-28 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 242 participants (enrolled count; ClinicalTrials.gov record NCT04454788, source copy `cardio:ctgov-nct04454788-2025-01-15`, retrieved 2026-10-26)
- Started: 2020-08-01 (actual) (ClinicalTrials.gov record NCT04454788, source copy `cardio:ctgov-nct04454788-2025-01-15`, retrieved 2026-10-26)
- Primary completion: 2024-07-28 (actual) (ClinicalTrials.gov record NCT04454788, source copy `cardio:ctgov-nct04454788-2025-01-15`, retrieved 2026-10-26)
- Completion: 2025-01-06 (actual) (ClinicalTrials.gov record NCT04454788, source copy `cardio:ctgov-nct04454788-2025-01-15`, retrieved 2026-10-26)
- Countries: Australia (ClinicalTrials.gov record NCT04454788, source copy `cardio:ctgov-nct04454788-2025-01-15`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "TERMINATED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04454788-2025-01-15`, retrieved 2026-10-26)

## The registry's words

- Brief title: Extending the Time Window for Tenecteplase by Effective Reperfusion in Patients with Large Vessel Occlusion
- Acronym: ETERNAL-LVO
- Condition: Ischemic Stroke
- Intervention (Drug): Tenecteplase
- Intervention (Drug): Standard Care (which may include intravenous Alteplase)
- Lead sponsor: University of Melbourne
- Lead sponsor class: OTHER
- Collaborator: Professor Mark Parsons
- Collaborator class: UNKNOWN

## Connected pages

- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry intervention name matches this record: Tenecteplase (`cardio:tenecteplase`)
- Registry intervention is a member of this class by a sourced record link: Fibrinolytic (clot-dissolving) drugs (`cardio:fibrinolytic-clot-dissolving-drugs`)
- Registry lists this organization as the lead sponsor: University of Melbourne (`cardio:org-university-of-melbourne`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Efficacy of Tenecteplase in Large Vessel Occlusion Stroke Within 24 Hours of Symptom Onset: The ETERNAL-LVO Randomized Controlled Trial (`cardio:pubmed-40927857`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 301df9b8c26614689fd81e97a2090d1a5cf8f6c5d6e7e6299504140ed07c05fa
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
